Aridis Pharmaceuticals, Inc. (ARDS) — Analyst outlook / Analyst consensus target is. Based on 7 analyst ratings, the consensus is bullish — 6 Buy, 1 Hold.
ARDS Analyst Ratings
Buy
7
Ratings
6 Buy
1 Hold
Based on 7 analysts giving stock ratings to Aridis Pharmaceuticals, Inc. in the past 3 months
